GlassScriptPhysician profile
Navid Redjal
NPI 1225297864
$4,243.52
in general payments reported to CMS, 2019-2025
8 companies · $1,406 in 2025
The $1,406 reported for 2025 was more than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $197 · 2021: $12.08 · 2022: $37.40 · 2023: $2,508 · 2024: $82.90 · 2025: $1,406.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,598 · Food and Beverage: $398.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,598.42 |
| Food and Beverage | $398.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Brainlab, INC. | $2,634.74 | 2019-2023 | Image Guided Surgical Device |
| Medtronic, INC. | $1,333.51 | 2025 | Visualase |
| Telix Pharmaceuticals | $82.90 | 2024 | |
| Olympus America INC. | $70.75 | 2019 | |
| Icotec Medical INC. | $51.02 | 2025 | Kong-Tl Vbr E, Expandable Body, L, 19 Mm X 27 - 37 Mm, Kong-Tl Vbr, End Plate, Rectangular, M and Screw, 12 X 33 Mm, Kong-Tl Vbr, End Plate, Round, L and Screw, 12 X 43 Mm |
| Ethicon US, LLC | $37.40 | 2022 | |
| Gt Medical Technologies, INC | $21.12 | 2025 | Gammatile |
| Integra Lifesciences Corporation | $12.08 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Navid Redjal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.